View Full Paper

Telemedicine for Pharmaceutical Firms: Roi And Performance Metrics | Post-Pandemic Lessons

• NLP
• IoT
• Impact

Abstract

This essay investigates “Telemedicine for Pharmaceutical Firms: Roi And Performance Metrics | Post-Pandemic Lessons” using a randomized controlled trial design. Through a economic lens, the analysis integrates multi-source data to derive an actionable roadmap for researchers and practitioners.